Stephen Michael Kelsey files SEC Form 4 disclosures for Revolution Medicines, Inc.. They have made 19 open-market trades across 2 companies since 2010, most recently 2026-09-16.
CIK 0001462808
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $199.24 | $1.1M | +6.8% | — | — |
| RVMD | SELL · 10b5-1 | 2026-09-11 | 2026-09-15 | $202.36 | $18.7M | -0.1% | -7.7% | — |
| RVMD | SELL · 10b5-1 | 2026-06-16 | 2026-06-18 | $156.12 | $652K | +15.5% | +11.1% | +20.8% |
| RVMD | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $99.48 | $856K | -0.7% | +49.3% | +61.1% |
| RVMD | SELL · 10b5-1 | 2025-12-16 | 2025-12-18 | $76.82 | $837K | +2.7% | +49.8% | +26.5% |
| RVMD | SELL · 10b5-1 | 2025-10-13 | 2025-10-15 | $48.54 | $1.2M | +16.0% | +35.5% | +139.9% |
| RVMD | SELL · 10b5-1 | 2025-09-16 | 2025-09-18 | $45.82 | $492K | +2.6% | +18.7% | +68.6% |
| RVMD | SELL · 10b5-1 | 2025-09-11 | 2025-09-15 | $44.46 | $11.1M | -8.1% | +7.1% | +70.7% |
| RVMD | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $39.83 | $342K | -7.8% | -4.2% | +11.8% |
| RVMD | SELL · 10b5-1 | 2025-03-17 | 2025-03-19 | $39.04 | $257K | -7.4% | -4.2% | +2.5% |
| RVMD | SELL · 10b5-1 | 2024-12-16 | 2024-12-18 | $45.40 | $423K | +1.0% | -7.0% | -11.9% |
| RVMD | SELL · 10b5-1 | 2024-11-13 | 2024-11-15 | $58.66 | $2.0M | +5.9% | -19.2% | -25.3% |
| RVMD | SELL · 10b5-1 | 2024-10-14 | 2024-10-16 | $49.49 | $1.6M | -5.5% | +9.1% | -21.2% |
| RVMD | SELL · 10b5-1 | 2024-09-16 | 2024-09-18 | $44.19 | $412K | -0.2% | +11.0% | -0.6% |
| RVMD | SELL · 10b5-1 | 2024-09-13 | 2024-09-16 | $43.33 | $1.4M | -0.8% | +14.0% | +1.1% |
| RVMD | SELL · 10b5-1 | 2024-08-13 | 2024-08-15 | $42.98 | $1.4M | +0.4% | +2.6% | +33.8% |
| RVMD | SELL · 10b5-1 | 2024-07-15 | 2024-07-17 | $46.49 | $1.3M | -0.9% | -7.6% | +5.7% |
| RVMD | SELL · 10b5-1 | 2024-06-24 | 2024-06-26 | $39.06 | $1.3M | +14.2% | +20.8% | +15.5% |
| RVMD | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $37.39 | $250K | -0.6% | +27.5% | +17.2% |
| RVMD | SELL · 10b5-1 | 2024-03-18 | 2024-03-20 | $31.58 | $134K | -2.5% | +10.2% | +19.0% |
| RVMD | SELL · 10b5-1 | 2024-01-08 | 2024-01-10 | $29.01 | $194K | -2.3% | +8.7% | +17.8% |
| RVMD | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $29.10 | $388K | -5.0% | +6.6% | +11.2% |
| RVMD | SELL · 10b5-1 | 2023-12-27 | 2023-12-29 | $29.01 | $1.9M | -0.3% | +1.8% | +13.6% |
| RVMD | SELL · 10b5-1 | 2023-12-18 | 2023-12-20 | $25.90 | $108K | +6.8% | +2.7% | +17.5% |
| RVMD | SELL · 10b5-1 | 2023-10-11 | 2023-10-13 | $29.05 | $968K | -33.1% | -34.3% | -5.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.